高级检索
当前位置: 首页 > 详情页

Association between Proliferative Diabetic Retinopathy and Serum Bile Acid Level in Patients with Type 2 Diabetes Mellitus

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Tongren Hosp, Dept Endocrinol, 1 Dongjiaomin Alley, Beijing 100730, Peoples R China
出处:
ISSN:

关键词: Type 2 diabetes mellitus diabetic retinopathy serum bile acid oxidative stress tauroursodeoxycholic acid ursodeoxycholic acid

摘要:
Background: Diabetic retinopathy (DR) is one of the diabetic microvascular complica-tions, which is also one of the important causes of blindness in adults. Objective: To investigate the association between proliferative retinopathy and serum bile acid lev -el in patients with type 2 diabetes mellitus (T2DM). Methods: Three hundred and thirty-six patients with T2DM were included, of which, 229 had a his-tory of more than 10 years without diabetic retinopathy (no diabetic retinopathy, NDR) and 107 had proliferative diabetic retinopathy (PDR). The baseline characteristics of the two groups were compared. According to the level of bile acid, the patients were divided into low, medium and high bile acid groups. The ratio of proliferative retinopathy in each group was compared. The presence of retinopathy was taken as the dependent variable, and the significant variables were analyzed by logistic regression. Results: The level of total bilirubin and bile acid in the NDR group was significantly higher than that in the PDR group, while the levels of triglyceride, cholesterol and LDL-C were significantly lower than that in the PDR group (P<0.05). With the increase of bile acid level, the proportion of proliferative retinopathy decreased. Logistic regression analysis showed that bilirubin and bile acid were protective factors of diabetic retinopathy, while SBP, LDL-C and UAER were risk factors of diabetic retinopathy. Conclusion: Bile acid might be a protective factor for diabetic retinopathy in T2DM, which might be a potential therapeutic role in retinal disorders.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 免疫学 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 免疫学 4 区 药学
JCR分区:
出版当年[2019]版:
Q3 PHARMACOLOGY & PHARMACY Q4 IMMUNOLOGY Q4 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q3 ENDOCRINOLOGY & METABOLISM Q3 PHARMACOLOGY & PHARMACY Q4 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Capital Med Univ, Tongren Hosp, Dept Endocrinol, 1 Dongjiaomin Alley, Beijing 100730, Peoples R China [*1]10th Floor, West District, Department of Endocrinology, Tongren Hospital, Capital Medical University, No.1 dongjiaomin Alley, Dongcheng District Beijing, 100730, China
通讯作者:
通讯机构: [1]Capital Med Univ, Tongren Hosp, Dept Endocrinol, 1 Dongjiaomin Alley, Beijing 100730, Peoples R China [*1]10th Floor, West District, Department of Endocrinology, Tongren Hospital, Capital Medical University, No.1 dongjiaomin Alley, Dongcheng District Beijing, 100730, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)